Claire Lucas

2.3k total citations
37 papers, 1.7k citations indexed

About

Claire Lucas is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Claire Lucas has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 14 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Claire Lucas's work include Chronic Myeloid Leukemia Treatments (19 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Cell Adhesion Molecules Research (7 papers). Claire Lucas is often cited by papers focused on Chronic Myeloid Leukemia Treatments (19 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Cell Adhesion Molecules Research (7 papers). Claire Lucas collaborates with scholars based in United Kingdom, Australia and France. Claire Lucas's co-authors include Richard E. Clark, Gordon F. Burns, Athina Giannoudis, Robert J. Harris, Michael C. Berndt, Michael P. Skinner, Lihui Wang, Joseph T. Byers, C.N. Chesterman and Martin Welch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Claire Lucas

37 papers receiving 1.6k citations

Peers

Countries citing papers authored by Claire Lucas

Since Specialization

Citations

This map shows the geographic impact of Claire Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Lucas more than expected).

Fields of papers citing papers by Claire Lucas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Lucas. The network helps show where Claire Lucas may publish in the future.

Co-authorship network of co-authors of Claire Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Lucas. A scholar is included among the top collaborators of Claire Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Lucas. Claire Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML 2023 ·Oncogene ·(unknown), (unknown), (unknown), Michael J. Randles, Luca Cozzuto, Vinothini Rajeeve, Armando Cevenini, (unknown), Gabriella Esposito, Julia Ponomarenko, Claire Lucas, Pedro R. Cutillas, John G. Gribben, Owen Williams, Yolanda Calle, Bela Patel, Maria Teresa Esposito	3
2	Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias 2021 ·Clinical Cancer Research ·(unknown), Karolina Pavic, (unknown), Urpu Salmenniemi, Eliisa Löyttyniemi, (unknown), Tea Ammunét, Veli‐Matti Kähäri, Richard E. Clark, Laura L. Elo, (unknown), Claire Lucas, Maija Itälä‐Remes, Jukka Westermarck	12
3	Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5′ AMP-activated protein kinase signalling in malignant cells 2019 ·Biochemical Journal ·James Austin, Rosalind E. Jenkins, (unknown), Mark Glenn, Karen Dunn, Laura J. Scott, Claire Lucas, Richard E. Clark	3
4	High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia 2016 ·Leukemia ·Claire Lucas, (unknown), Michael Butterworth, (unknown), Laura J. Scott, Richard E. Clark, Gerald M. Cohen, Shankar Varadarajan	22
5	Turning Squalene into Cationic Lipid Allows a Delivery of siRNA in Cultured Cells 2015 ·Nucleic Acid Therapeutics ·Jean‐Rémi Bertrand, Claire Lucas, Ngoc Minh Pham, Catherine Pioche‐Durieu, Patrick Couvreur, Claude Malvy, Didier Desmaële	5
6	Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients 2015 ·Leukemia ·Claire Lucas, Robert J. Harris, (unknown), Laura J. Scott, (unknown), Elizabeth S. McDonald, (unknown), R E Clark	27
7	Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemia 2014 ·Haematologica ·Claire Lucas, R. J. C. Harris, Athina Giannoudis, Elizabeth S. McDonald, R E Clark	13
8	A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia 2013 ·Leukemia Research ·Sebastian Francis, Claire Lucas, Steven Lane, Lihui Wang, (unknown), Katy Knight, Jo Bell, (unknown), Edwin Lee, David O’Brien, Nauman M. Butt, (unknown), (unknown), (unknown), Rahuman Salim, Richard E. Clark	9
9	Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression 2011 ·Blood ·Claire Lucas, Robert J. Harris, Athina Giannoudis, Mhairi Copland, Joseph R. Slupsky, Richard E. Clark	111
10	Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters 2009 ·Leukemia ·Andrea Davies, Niove E. Jordanides, Athina Giannoudis, Claire Lucas, Sophia Hatziieremia, Robert J. Harris, Heather G. Jørgensen, Tessa L. Holyoake, Munir Pirmohamed, R E Clark, Joanne C. Mountford	84
11	Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript 2009 ·Haematologica ·Claire Lucas, Robert J. Harris, Athina Giannoudis, Andrew Davies, K.R. Knight, (unknown), Lihui Wang, R E Clark	87
12	Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia 2008 ·Blood ·Athina Giannoudis, Andrea Davies, Claire Lucas, Robert J. Harris, Munir Pirmohamed, Richard E. Clark	100
13	Chemokine Receptors Expression and Migration Potential of Tumor-infiltrating and Peripheral-expanded Vγ9Vδ2 T Cells From Renal Cell Carcinoma Patients 2008 ·Journal of Immunotherapy ·(unknown), Claire Lucas, François Romagné, Bernard Escudier, Salem Chouaı̈b, Anne Caignard	40
14	Nilotinib concentration in Cell Lines and CML CD34+ Cells Is Not Mediated by Active Uptake or Efflux by Major Drug Transporters 2008 ·Blood ·Joanne C. Mountford, Andrea Davies, Niove E. Jordanides, Athina Giannoudis, Claire Lucas, Sophia Hatziieremia, R. J. C. Harris, Heather G. Jørgensen, Munir Pirmohamed, Tessa L. Holyoake, Richard E. Clark	2
15	Characterisation of Nilotinib Transport in Chronic Myeloid Leukaemia Cells. 2007 ·Blood ·Andrea Davies, Athina Giannoudis, Claire Lucas, Robert J. Harris, Paul W. Manley, Munir Pirmohamed, Richard E. Clark	4
16	Effect of S9788 on the efficiency of doxorubicin in vivo and in vitro in medullary thyroid carcinoma xenograft 1996 ·Anti-Cancer Drugs ·Catherine Massart, J Gibassier, (unknown), (unknown), (unknown), F. Darcel, Claire Lucas	3
17	GMP-140 binding to neutrophils is inhibited by sulfated glycans. 1991 ·Journal of Biological Chemistry ·Michael P. Skinner, Claire Lucas, Gordon F. Burns, C.N. Chesterman, Michael C. Berndt	173
18	Identification of a novel integrin beta subunit expressed on cultured monocytes (macrophages). Evidence that one alpha subunit can associate with multiple beta subunits. 1990 ·Journal of Biological Chemistry ·G W Krissansen, Michael J. Elliott, Claire Lucas, Frank C. Stomski, MC Berndt, David A. Cheresh, Angel F. López, Gordon F. Burns	81
19	Environmental coping strategies for Alzheimer's caregivers 1989 ·American Journal of Alzheimer s Care and Related Disorders & Research ·Jon Pynoos, (unknown), Claire Lucas	11
20	Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils. 1988 ·PubMed ·(unknown), Angel F. López, Wayne A. Marasco, Claire Lucas, GG Wong, G F Burns, M A Vadas	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact